Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/IRCT20200502047269N1
IRCT20200502047269N1RecruitingPhase 3

Comparison of the sedative effect of Remifentanil and Dexmidetomidine in patients undergoing venous arterial fistula implantation

Iran University of Medical Sciences0 sites32 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
32
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
19 years to 60 years (—)
Sex
All

Inclusion Criteria

  • •Age group 19 to 60 years
  • •Patients with stable hemodynamic status

Exclusion Criteria

  • •Patients with a history of cardiovascular abnormalities
  • •Patients with a history of chronic diseases such as liver disease
  • •Patients with a history of allergies to anesthetics, including opioids
  • •Patients with a history of opium use
  • •Pregnant or lactating women
  • •Recent respiratory tract infection
  • •Severe bronchopulmonary disease

Investigators

Similar Trials

Completed
Phase 2
Sedative effect of Remifentanil in Senile Cataract SurgeriesCataract.Senile incipient cataract
IRCT201111268201N1Vice chancellor for research, Tehran University of Medical Sciences60
Completed
Phase 2
Remifentanil infusion effect on oocyte retrievalAnethestics complication and efficacy.Complications of anaesthesia during pregnancy
IRCT201611177013N15Vice chancellor for research, Tabriz University of medical sceinces180
Completed
Not Applicable
Comparison of effects of Remifentanil and Fentanyl in blood pressure and heart rate changes due to tracheal intubation in preeclamptic pregnant women candidate for cesarean sectiopreeclampsia.Gestational [pregnancy-induced] hypertension with significant proteinuria
IRCT201108294969N2Tehran University of Medical Science34
Completed
Phase 2
Evaluation of comparison between Remifentanil infusion and single dose intravenous Hydralazine + Propranolol administration to provide controlled hypotension in patients undergoing Rhino plastic surgery in khalili hospital during 2014-2015Hypertension.Hypertensive diseasesI10-I15
IRCT2015101522173N2Shiraz University of Medical Sciences80
Not yet recruiting
Phase 4
Comparative study between intravenous remifentanil and intravenous fentanyl in controlling blood pressure, Heartrate in patients undergoing General Anaesthesia.
CTRI/2024/05/067293Pondicherry Institute of Medical Sciences